scholarly journals Clinical case of the secondary glaucoma treatment in a dog by transscleral cyclophotocoagulation

Author(s):  
Sergey Kartashov ◽  
Maria Oboeva ◽  
Evgenia Kartashova ◽  
Alexandr Butenkov ◽  
Anastasia Rakityanskaya ◽  
...  
2019 ◽  
Vol 135 ◽  
pp. 01071
Author(s):  
Sergey Kartashov ◽  
Maria Oboeva ◽  
Evgenia Kartashova ◽  
Alexandr Butenkov ◽  
Anastasia Rakityanskaya ◽  
...  

Glaucoma is a common disease in animals, often leading to blindness. Nowadays, there are several treatments for glaucoma. One of promising technique is transscleral cyclophotocoagulation. This article presents a clinical case of treating a dog with bilateral secondary glaucoma complicated by optic atrophy and blindness of the right eye. Thanks to the combination of drug therapy and surgical treatment, a steady decrease in intraocular pressure was achieved.


2020 ◽  
pp. 112067212091423 ◽  
Author(s):  
Oya Tekeli ◽  
Helin Ceren Köse

Purpose: The aim of this study is to compare the outcomes of micropulse transscleral cyclophotocoagulation between primary open-angle glaucoma, pseudoexfoliation glaucoma, and other types of secondary glaucoma. Methods: Outcomes of 96 consecutive patients with refractory, end-stage glaucoma treated with micropulse transscleral cyclophotocoagulation were retrospectively reviewed. Follow-up examinations were performed on a regular basis until 12 months postoperatively. Surgical successes were defined as maintaining intraocular pressure ⩽18 mmHg and ⩾20% reduction in intraocular pressure (criteria A), ⩽15 mmHg intraocular pressure and ⩾25% reduction in intraocular pressure (criteria B), and ⩽12 mmHg intraocular pressure and ⩾30% reduction in intraocular pressure from baseline (criteria C). Results: Ninety-six eyes of 96 patients (50 (52%) females, 46 (48%) males) were included. Among all eyes, 32 were primary open-angle glaucoma, 30 were pseudoexfoliation glaucoma, and 34 were other types of secondary glaucoma. The mean age was 59.37 ± 11.45 (range: 20–91) years. The mean follow-up period was 14.2 ± 3.9 (range: 12–16) months. At 12 months, the success rates of primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma group were 68.75%, 66.6%, and 64.7% (p = 0.185) for criteria A; 56.25%, 53.3%, and 50% (p = 0.153) for criteria B; and 43.75%, 43.3%, and 38.2% (p = 0.146) for criteria C. Four patients (12.5%) in primary open-angle glaucoma group, 5 patients (16.6%) in pseudoexfoliation glaucoma group, and 14 (41.2%) patients in other secondary glaucoma group required reoperation during the follow-up (p < 0.05). Conclusion: Micropulse transscleral cyclophotocoagulation is an equally effective method of lowering intraocular pressure in patients with primary open-angle glaucoma, pseudoexfoliation glaucoma, and other types of secondary glaucoma. The rate of reoperation was higher in refractory secondary glaucoma patients.


2021 ◽  
Author(s):  
Duri Seo ◽  
Taek June Lee ◽  
Joo Yeon Kim ◽  
Wungrak Choi ◽  
Sang Yeop Lee ◽  
...  

Abstract This study evaluated the clinical outcomes of first-time micropulse transscleral cyclophotocoagulation (MP-TSCPC) performed in cases of refractory glaucoma. This retrospective study analysed the patients with refractory glaucoma who underwent MP-TSCPC rom February 2018 to February 2020 at Yonsei University Severance Hospital. A total of 45 eyes of 43 Asian patients (aged 55.71±16.84 years) who underwent MP-TSCPC for the first time, were included in this study. The mean baseline intraocular pressure (IOP) was 25.96±9.27 mmHg. The most common diagnosis was secondary glaucoma (44.4%) with a mean logarithm of the minimum angle of resolution (logMAR) visual acuity of 1.19±1.02. There was a significant reduction (P<0.05) in IOP on 1 day 1,to 18.03±5.99 mmHg;, at 1 week, to 13.29±5.24 mmHg;, at 1 month, to 14.98±4.55 mmHg;, at 3 months, to 17.05±5.52 mmHg;, 6 months to 17.78±6.37 mmHg; and 12 months, to 16.56±5.96 mmHg. There was also a reduction (P<0.05) in the number of topical anti-glaucoma medications required to control IOP from baseline (3.69±0.63) at 1, 3, and 6 months. MP-TSCPC is an effective procedure that offers good results in reducing IOP and decreases the use of anti-glaucoma medications in patients with refractory glaucoma.


2019 ◽  
Vol 12 (3) ◽  
pp. 45-58
Author(s):  
Tatyana V. Sokolovskaya ◽  
Maria I. Tikhonova

This article presents a historical evolution review of cyclodestructive methods in glaucoma treatment. It also provides the analysis of mechanism of action for each technology, their advantages and disadvantages. Results of clinical studies and most frequent complications of cyclodestructive procedures are also presented. The main attention is paid to the new MicroPulse laser technology, which is used for the treatment of primary open-angle glaucoma at various stages in patients with high visual acuity, as well as refractory forms of glaucoma. Data of clinical and experimental morphological studies of various modifications of transscleral cyclophotocoagulation technology are specified. Theories, research hypothesis upon the mechanism of MicroPulse laser action. In most researchers opinion, despite the relatively short observation period (from 6 months to 5 years), MicroPulse technology is recognized as effective and advanced.


2021 ◽  
Vol 14 (3) ◽  
pp. e239585
Author(s):  
Pratinya Gowri Kolipaka ◽  
Rashmi Krishnamurthy ◽  
Bhupesh Bagga

We report a case of a 7-year-old boy, who presented with plate exposure after Ahmed glaucoma valve (AGV) implantation in the eye with secondary glaucoma following penetrating trauma. He underwent AGV explantation with scleral patch graft and conjunctival limbal autograft and started on topical and oral antiglaucoma medication (AGM) for intraocular pressure (IOP) control. Two months later, he presented to us with high intraocular pressure and uveal tissue prolapse at the site of previous tube entry displacing the scleral and conjunctival grafts posteriorly. The defect was closed with corneal patch graft. Patient underwent limited transscleral cyclophotocoagulation and was maintained on topical AGM for IOP control. Our case highlights that explantation is a definitive management in such cases of plate exposure. Tube entry site is a potential weak area and there is risk of uveal prolapse through this area with high IOP. Corneal patch graft helps in successfully managing such defects involving the sclero-limbal region.


2021 ◽  
pp. 77-79
Author(s):  
N.V. Gorbacheva ◽  
◽  
S.I. Makogon ◽  
D.I. Ivanova ◽  
J.S. Hlopkova ◽  
...  

Frank-Kamenetsky syndrome is a rather rare ocular anomaly, which is characterized by hypoplasia of the iris stroma with exposure of its pigment layer and the development of secondary glaucoma, more often in the 2-3rd decade of life. Gonioscopy reveals goniodysgenesis in the form of "dentate" and anterior attachment of the root of the iris of a dirty gray color, as well as the inclusion of mesodermal tissue in the trabecular zone. The severity of the course of glaucoma is determined by the age of onset and is often malignant, gradually leading to blindness. Frank-Kamenetsky syndrome is observed in men and refers to a recessive disease linked to the X chromosome. The article presents a clinical case of mesenchymal iris dysplasia, first identified in a family, similar to the clinical picture of Frank-Kamenetsky syndrome. Previously, retinal pigment degeneration was observed in the male line of the family. Key words: Frank-Kamenetsky syndrome, glaucoma, congenital glaucoma.


Sign in / Sign up

Export Citation Format

Share Document